How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Close this folder2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contentsOrganization of the national formulary committee
View the documentAgreement on purpose, content, structure and format
View the documentFinancing
View the documentSelection of medicines to be included in the national formulary
View the documentDevelopment of the draft
View the documentReviewing and finalizing content
View the documentProduction, dissemination and implementation
View the documentEvaluation and review
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Agreement on purpose, content, structure and format

The WMF could serve as a model for the structure, content and depth of information provided in a NF. However, depending on the intended audience and purpose of the NF, substantial differences will still exist between countries with regard to inclusion of local drug policies, synopses of national guidelines and locally collected information on medicines. Therefore, the NFC and the editors should clearly define these attributes of the formulary and identify the procedures necessary to achieve them.

Important structural and formatting decisions regarding classification, indexing, number of sections, technicality of language, etc. will need to be made early in the drafting process. The development of a NF can be greatly facilitated by the extensive adoption of WMF structures and content. Clearly the intended purpose of a NF will strongly influence whether the NF will be a slim, compact drug handbook or a more substantial and comprehensive drug reference book. However, a balance will have to be struck between including all possible information and producing a manageable volume for everyday use. It is useful to look at other published formularies at this planning stage to obtain helpful ideas.

Developing a small “pilot” draft section of the formulary based on the WMF and discussing content and format issues again before the entire draft is developed can be a useful way to save editorial time and make production of the draft consistent.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014